semaglutide gastroparesis lawsuit in dallas attorney semaglutide constipation lawyer in dallas Ozempic Lawsuit-mvanhaasteren.nl semaglutide gastroparesis attorney in dallas

Could Retatrutide be the next breakthrough in medical weight loss

Canadians are expressing a growing interest in GLP-1 medications such as Ozempic and Mounjaro for weight loss, that increased demand has prompted a Health Canada advisory about the risk of unauthorized or counterfeit products

ReNew Me Medical Group is Roseville, CA's holistic weight loss and wellness clinic

A UCLA study published in ACR Open Rheumatology found that GLP-1 receptor agonists such as semaglutide and tirzepatide may reduce rheumatoid arthritis activity and cardiovascular risk factors in people with obesity, suggesting potential dual benefits for metabolic and inflammatory health.

This study is a game-changer

Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD).